CD133+ circulating haematopoietic progenitor cells predict for response to sorafenib plus erlotinib in non-small cell lung cancer patients

Increased numbers of small circulating endothelial cells in renal cell cancer patients treated with sunitinib

(2009) Laura Vroling et al.   ANGIOGENESIS

Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors

(2009) R Kumar et al.   BRITISH JOURNAL OF CANCER

Endothelial progenitor cell: ongoing controversy for defining these cells and their role in neoangiogenesis in the murine system

(2009) Mervin C Yoder et al.   CURRENT OPINION IN HEMATOLOGY

Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinib

(2009) Henk J. Broxterman et al.   DRUG RESISTANCE UPDATES

Phase I Study of Concurrent Whole Brain Radiotherapy and Erlotinib for Multiple Brain Metastases From Non–Small-Cell Lung Cancer

(2009) Joline S.W. Lind et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

(2009) Andrew X. Zhu et al.   JOURNAL OF CLINICAL ONCOLOGY

Combined Inhibition of the VEGFR and EGFR Signaling Pathways in the Treatment of NSCLC

(2009) N. A. Pennell et al.   ONCOLOGIST

Circulating Angiogenic Precursors in Idiopathic Pulmonary Arterial Hypertension

(2008) Kewal Asosingh et al.   AMERICAN JOURNAL OF PATHOLOGY

Circulating and imaging markers for angiogenesis

(2008) Arvind P. Pathak et al.   ANGIOGENESIS

Assessing Identity, Phenotype, and Fate of Endothelial Progenitor Cells

(2008) Karen K. Hirschi et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Cell Adhesion Molecules, Vascular Endothelial Growth Factor, and Basic Fibroblast Growth Factor in Patients with Non-Small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab--an Eastern Cooperative Oncology Group Study

(2008) A. Dowlati et al.   CLINICAL CANCER RESEARCH

Progress and challenges in the identification of biomarkers for EGFR and VEGFR targeting anticancer agents

(2008) Christophe Le Tourneau et al.   DRUG RESISTANCE UPDATES

Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies

(2008) Farbod Shojaei et al.   DRUG RESISTANCE UPDATES

Cancer clinical trial outcomes: Any progress in tumour-size assessment?

(2008) Jaap Verweij et al.   EUROPEAN JOURNAL OF CANCER

Bevacizumab for the treatment of advanced non-small-cell lung cancer

(2008) Christian Manegold   Expert Review of Anticancer Therapy

Endothelial progenitor cells: identity defined?

(2008) Frank Timmermans et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Tumor Cavitation: Impact on Objective Response Evaluation in Trials of Angiogenesis Inhibitors in Non–Small-Cell Lung Cancer

(2008) Simon J. Crabb et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumor Angiogenesis

(2008) Robert S. Kerbel   NEW ENGLAND JOURNAL OF MEDICINE